2026 NMD4C Application & Nomination Deadlines
As we get the new year started, we’ve got three NMD4C opportunities you won’t want to miss that are all closing shortly!
Nominate a researcher for one of our Annual NMD4C Awards:
There are three awards categories:
- Early Career Biomedical Researcher of the Year,
- Early Career Clinical Researcher of the Year and,
- Publication of the Year.
Learn More & Apply by Jan 23, 2026
Apply to join the NMD4C Basic Science Trainee Committee (BSTC):
The NMD4C BSTC is now accepting applications from graduate students and postdoctoral fellows who are eager to get involved. Join a national network of trainees working together to strengthen neuromuscular research across Canada, while building skills in leadership, communication, and program development.
Learn More & Apply by Jan 23, 2026
Apply to attend the 2026 NMD4C Basic Research Summer School:
Led by Dr. Mireille Khacho, the 2026 NMD4C Basic Research Summer School will be held from June 8th to 10th at the University of Ottawa. The program offers demos, tutorials, lecture-based and hands-on training workshops to neuromuscular trainees in cutting-edge wet lab techniques, while providing an environment for trainees to present their research and network in-person with colleagues and investigators from across Canada.
Supporting pre-clinical trainees and scientists is a key focus of the network, and we are aiming to make this event as accessible as possible for trainees to attend from across Canada. Registration is free, and accommodations and travel will be provided for non-local participants.
Apply by Jan 27, 2026 to attend!
Read next...
New Publication from the NMD4C Clinical Trial Network Strengthens Trial Capacity in Canada
We are pleased to share a new publication from the NMD4C Clinical Trial Network led by Kerri Lynn Schellenberg, Homira Osman, Maria Masnata, Rhiannon Hicks, Corinne Kagan, Ana Stosic, Stacey Lintern, Erin Beattie, Drs. Hanns Lochmüller, Craig Campbell, and Jean K Mah. This work focuses on the implementation of a coordinated Canadian neuromuscular clinical trial network to enhance trial readiness, capacity, and access in rare disease research.
Canadian-Led Phase II Studies Advance Vamorolone Evidence in Duchenne Muscular Dystrophy
NMD4C investigators contributed to two phase II studies evaluating vamorolone in boys with Duchenne muscular dystrophy across early childhood and adolescence, demonstrating safety, favorable pharmacokinetics, and potential efficacy. Led by Dr. Jean Mah and conducted across Canadian clinical trial sites with national and industry collaborators, the findings supported Health Canada approval of vamorolone as the first treatment for DMD in Canada. Leaders from both the clinical and patient advocacy communities, including Defeat Duchenne Canada, highlighted the impact of collaboration among patients, families, clinicians, and researchers in advancing care and improving access to new therapies.
Advancing AFC in Neuromuscular Medicine: Program Launch & September Workshop
The Royal College has approved National Training Standards for the AFC in Neuromuscular Medicine, creating a formal pathway to recognize enhanced competence with the DRCPSC credential. This designation establishes a national training standard, supports portable certification, and strengthens clinical capacity across Canada. PGME offices can now apply to offer accredited AFC programs, with a goal of five programs submitting applications by the end of 2026.